1. IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA IN THE RANDOMISED PHASE III GALLIUM STUDY: ANALYSIS BY CHEMOTHERAPY REGIMEN. (June 2017) Authors: Hiddemann, W.; Barbui, A.M.; Canales Albendea, M.A.; Cannell, P.K.; Collins, G.P.; Dürig, J.; Forstpointner, R.; Herold, M.; Hertzberg, M.; Klanova, M.; Radford, J.A.; Tobinai, K.; Burciu, A.; Fingerle‐Rowson, G.R.; Nielsen, T.; Wolbers, M.; Marcus, R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗